Astranordic BPC/TB Pen · 20 mg BPC-157 + 20 mg TB-500 (pre-filled pen)- ·Pre-filled pen (40 mg total — 20+20)
- ·Alcohol swabs
BPC-157 + TB-500 20/20 mg pen
High-dose pen format — 20 mg BPC-157 + 20 mg TB-500.
High-dose pen format of the BPC-157 + TB-500 blend. Double the dose of the standard vial kit, in a pre-filled pen device.
What the peptide is.
The Astranordic pen range provides pre-filled research peptides in a clinical-style pen format. The BPC / TB-500 pen carries 20 mg of each peptide, suitable for extended preclinical tissue-repair protocols.
As per individual peptides — see BPC-157 and TB-500 entries.
Reconstitution, storage, and handling.
Lab-technical guidance for the researcher handling the material. Not therapeutic dosing, not administration guidance — those are not within the scope of this supply.
- Recommended solvent
- Pre-reconstituted
- Typical volume
- N/A
- Cold-chain shipped; refrigerate on receipt.
- Lyophilised
- Pre-filled pen — store 2–8 °C. Pen is shipped cold-chain; after first use it may be kept at 2–8 °C.
- Reconstituted
- Pens are pre-reconstituted. Once opened, use within the manufacturer-stated window (typically 4 weeks refrigerated).
- Shelf life · sealed
- See pen label — typically 18–24 months sealed under refrigeration.
- Shelf life · reconstituted
- Once pen is opened: ~4 weeks at 2–8 °C.
- ▸Cold-chain dispatch.
- ▸Once opened, refrigerated, use within ~4 weeks.
This lot, documented.
Every shipment is accompanied by a signed four-page analytical report including the HPLC chromatogram, ESI-MS spectrum, purity calculation, and sample handling chain-of-custody.
The report you will receive is specific to the lot dispatched to you. The display below is a current representative example.
04:22:11▸lot 26-04-A received ┈ 5.00 g04:22:40▸weight check ┈ PASS ±0.4 mg04:23:12▸sample → janoshik ┈ 50 mg04:23:12▸tracking #jnk-921833405:18:03▸HPLC result ┈ 99.24 %05:18:04▸MS obs 4729.42 Da ┈ PASS05:18:05▸coa.pdf signed ┈ attached05:18:06▸lot approved ┈ LIVE
REPORT ID JA-26-04-012
SUBJECT BPC-157 + TB-500 20/20 mg pen
DESIGNATION Astranordic BPC/TB Pen
LOT 26-04-A
METHOD RP-HPLC, ESI-MS
COLUMN C18, 250 x 4.6 mm, 5 um
MOBILE PHASE A: 0.1% TFA in H2O
B: 0.1% TFA in ACN
GRADIENT 5 -> 65% B over 20 min
FLOW RATE 1.0 mL/min
DETECTION UV 214 nm
INJECTION 20 uL @ 0.5 mg/mL
---
PURITY (A%) 99.00
MASS EXP. —
MASS OBS. —
---
CONCLUSION Identity CONFIRMED · Purity PASS
SIGNED BY J. Novak, MSc · Janoshik Analytical SVK
DATE 2026-04-11Research references for BPC-157 + TB-500 20/20 mg pen.
0 peer-reviewed publications. Links resolve to PubMed. DOIs are provided where available.
- Q.Why a pen rather than a vial?
- A.Researchers running extended protocols often prefer the pen format for measurement convenience. The active peptides are identical to the vial kit.
This peptide is supplied by Omega Grade for in vitro laboratory research use. It is not a drug, food, cosmetic, or dietary supplement. It is not approved by the FDA, EMA, MHRA, PMDA, or any other regulatory authority for any therapeutic indication.
No claim of therapeutic benefit is made or implied. The material is not intended for human or veterinary consumption, administration, or any form of self-experimentation. By purchasing, you acknowledge the researcher terms and accept full responsibility for local import compliance and all handling.
Often considered alongside.
BPC-157 + TB-500 10/10 mg kit
Paired regenerative peptides — combined kit, most-requested blend.
- Form
- Lyophilised kit
- Dose
- 10 mg BPC-157 + 10 mg TB-500 / vial
- Purity
- ≥ 99.0% (both peptides)
BPC-157 15 mg
Pentadecapeptide — 15-residue fragment of a gastric body-protection protein.
- Form
- Lyophilised kit
- Dose
- 15 mg / vial
- Purity
- ≥ 99.4%
TB-500 10 mg
Synthetic thymosin β-4 — 43-residue actin-sequestering peptide.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.1%